Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001651308-21-000188)

Filing Details

Accession Number:: 0001651308-21-000188
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-02 20:39:22
Reporting Period:: 2021-08-31

Accepted Time:: 2021-09-02 20:39:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651308	Beigene Ltd.	BGNE	Pharmaceutical Preparations (2834)	981209416

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1683913	Jane Huang	C/O Mourant Governance Services (Cayman) 94 Solaris Avenue Camana Bay, Grand Cayman E9 KY1-1108	Cmo, Hematology	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2021-08-31	7,163	$0.00	305,824	No	4	A	Direct
Ordinary Shares	Acquisiton	2021-09-01	7,124	$0.00	312,948	No	4	A	Direct
American Depositary Shares	Acquisiton	2021-08-31	542	$0.00	542	No	4	A	Direct
American Depositary Shares	Disposition	2021-09-01	542	$310.53	0	No	4	S	Direct
American Depositary Shares	Acquisiton	2021-09-01	545	$0.00	545	No	4	A	Direct
American Depositary Shares	Disposition	2021-09-02	545	$327.18	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Footnotes

Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions.
Each American Depositary Share represents 13 Ordinary Shares.
The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a performance-based restricted share unit award previously granted to the Reporting Person.